Clinical experience with Bempedoic Acid
Christie Ballantyne
87th EAS Congress 2019
Pharmacology of Bempedoic acidGiuseppe Danilo Norata
87th EAS Congress 2019
What do we know so far about bempedoic acid?Kausik Ray
88th EAS Congress 2020
Bempedoic Acid – Mechanism of actionAlberico L. Catapano
An Introduction to Clinical Lipidology
Bempedoic Acid – The clinical experienceUlf Landmesser
An Introduction to Clinical Lipidology
Bempedoic acid – Mechanism of actionAlberico L. Catapano
Intro to Clinical Lipidology
Bempedoic acid in clinical practice updates from the MILOS studyMay 21, 2023 | 91th EAS Congress 2023, Re-thinking Lipid Management in Patients with High and Very High Cardiovascular Risk
Impact of bempedoic acid on cardiovascular events in high risk patients with statin intolerance: the clear outcomes studyStephen Nicholls
May 23, 2023 | 91th EAS Congress 2023, Late Breaker - Clinical
Low production of 12_-hydroxylated bile acids prevents hepatic steatosis in mice with a human-like bile acid pool by reducing fat absorptionAnna Palmiotti
May 24, 2022 | 90th EAS Congress 2022, Cardiometabolic Risk and Ectopic Fat | #
ACLY and atherosclerosis: lipids and beyondA tailor-made programme, exclusively for invited members of Daiichi-Sankyo scientific and medical team Overview & introduction This training programme is exclusively for invited members members…